Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Cannabis firm Canopy Growth said on Friday its CEO, David Klein, will retire at the end of the company's current fiscal year ending March 31, 2025.

Canopy Growth CEO to step down

David Klein, CEO to retire at the end of the Company's fiscal year Board of Directors expresses continued confidence in the Company's strategic direction and leadership team A comprehensive CEO selection process has been initiated to identify a successor This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement dated June 6, 2024 to its short form base shelf prospectus dated June 5, 2024. SMITHS FALLS, ON , Aug. 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, announced today that Mr.

Canopy Growth Announces CEO Succession Plan

Canopy Growth NASDAQ: CGC is one of the North American players in the cannabis industry. The company's shares have seen massive fluctuations since going public in 2014 under the name Tweed Incorporated.

Canopy Growth Stock: Can It Sustain Recent Gains?

Canopy Growth's AGM to be held in a virtual-only format on Tuesday, September 24, 2024 at 1:00 PM ET. Voting is important and easy; shareholders are encouraged to vote now.

Canopy Growth Announces Mailing and Filing of Annual General Meeting Materials

Aurora Cannabis

Green Thumb Industries Inc.

Trulieve Cannabis Corp.

Tilray Brands

Earnings from North American cannabis companies for the second quarter have been a mixed bag, with expansion into new markets, operational streamlining, and product innovation key themes across the sector. Many multi-state operations (MSOs) are turning to emerging, less saturated international markets for growth, notably, Germany, which kicked off expanded medical sales amid broader legalization measures on April 1.

Cannabis MSOs embrace new markets, streamline operations in Q2

A new survey from cannabis telehealth platform NuggMD says most Americans buy their marijuana legally when they can. Ten percent of cannabis buyers still mostly buy from illegal sources.

Why Canopy Growth Stock Popped on Monday

Canopy Growth Corporation (CGC) shares dropped Friday after the company's first-quarter fiscal 2025 earnings fell significantly short of expectations.

Canopy Growth Stock Falls After Disappointing Earnings, Slowing Sales

Canopy Growth (NASDAQ: CGC ) is among the top Canada-based cannabis producers that investors are watching for clues on how the overall legal marijuana market is performing. Today's decline of more than 8% in CGC stock suggests continued weakness may be forthcoming.

Canopy Growth Stock News: What's Going On With CGC Stock Today?

Canopy Growth Corporation. (NASDAQ:CGC ) Q1 2025 Earnings Conference Call August 9, 2024 10:00 AM ET Company Participants Tyler Burns - Director, IR David Klein - CEO Judy Hong - CFO Conference Call Participants Aaron Grey - Alliance Global Partners Frederico Gomes - ATB Capital Markets Michael Lavery - Piper Sandler William Kirk - Roth Capital Partners Operator Good morning.

Canopy Growth Corporation (CGC) Q1 2025 Earnings Call Transcript

The cannabis industry has experienced significant change since its inception twelve years ago.  Fueled by legalization trends and evolving social acceptance, this burgeoning sector has attracted considerable investment and innovation.

The Cannabis Sector: Profitability Takes Center Stage

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.37 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.40 per share a year ago.

Canopy Growth Corporation (CGC) Reports Q1 Loss, Lags Revenue Estimates

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) shares slipped almost 10% after it posted a widening loss for the fiscal first quarter and revenue fell short of expectations. The Smith Falls, Ontario-based cannabis producer posted a net loss of $127.1 million or C$1.60 per share, up from a loss of C$38.1 million of C$0.69 per share in the year-ago quarter.

Canopy Growth shares slump on widening quarterly loss, revenue miss

Canadian pot firm Canopy Growth reported a smaller-than-expected core loss for the first quarter on Friday, helped by lower operating expenses and stronger demand for medical cannabis.

Canopy Growth posts smaller-than-expected core loss as costs drop

Canopy Growth Corp. CGC, +8.29% WEED, +7.60% said Friday its first-quarter loss widened to C$127.14 million ($92.7 million), or C$1.60 a share, from C$41.86 million, or C$0.69 a share in the year-ago quarter. Adjusted loss of C$1.63 a share fell short of the FactSet consensus estimate for a loss of 46 cents a share.

Canopy Growth posts wider loss as revenue falls

Focus on profitable revenue generation delivered 67% increase in gross profit year-over-year Record quarter for Canada Medical Cannabis with Net Revenue increasing 20% year-over-year and 6th consecutive quarter of growth Extended maturity of senior secured term loan to December 18, 2026 with an option to further extend to September 18, 2027 SMITHS FALLS, ON , Aug. 9, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (Nasdaq: CGC) today announces its financial results for the first quarter ended June 30, 2024 ("Q1 FY2025"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Reports First Quarter Fiscal Year 2025 Financial Results

Curaleaf Holdings, Inc.

AdvisorShares Pure US Cannabis ETF

Cannabis stocks moved sharply higher in late afternoon trading on Thursday after Republican presidential nominee Donald Trump said he's shifting his position in favor of looser cannabis laws.

Cannabis stocks post sharp gains as Trump says he's starting to ‘agree more' about reforms

Scotts Miracle-Gro

SNDL Inc.

Make no mistake: it's still a time when you should be thinking about which cannabis stocks to sell, not which cannabis stocks to buy. Yes, based on the sheer volume of public comments submitted to the Drug Enforcement Administration ( DEA ) in support of a proposed rescheduling of marijuana, U.S. cannabis legalization progress seemingly keeps moving in the right direction.

7 Struggling Cannabis Stocks to Sell by 2025

There hasn't been any significant progress in terms of legalizing marijuana under President Biden. Kamala Harris may be the Democratic nominee, and she's favored marijuana reform in the past.

President Biden's Decision Not to Run for a Second Term Could Be a Massive Catalyst for Cannabis Stocks

Canopy Growth (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Canopy Growth Corporation (CGC) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Plug Power

SoundHound AI Inc

Canopy Growth's rate of cash burn has improved, but the cannabis company's lack of cash could be a growing concern for investors. Plug Power may no longer have a going concern warning, but there are still plenty of red flags surrounding its business.

3 Risky Stocks That Are Cash-Burning Machines

Canopy Growth Corporation (CGC) closed the most recent trading day at $7.60, making no change from the previous trading session.

Canopy Growth Corporation (CGC) Flat As Market Gains: What You Should Know

Cronos Group

Marijuana stock investors are prepping for future trading. Many who are invested in cannabis are focused on the long term. With how volatile the sector can be there have been some moments to take profits. However, with the need for better regulations and all-around reform planning for the future is where many feel the money is. Currently, there is no federal reform in place even with the DEA's approval to reschedule cannabis.

3 Marijuana Stocks For Investors To Trade Today

SMITHS FALLS, ON , July 26, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) will release its financial results for the first quarter fiscal year 2025 ended June 30, 2024 before financial markets open on August 9, 2024. Following the release of its first quarter fiscal year 2025 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on August 9, at 10 AM Eastern Time.

Canopy Growth to Report First Quarter Fiscal 2025 Financial Results on August 9, 2024

Marijuana legalization would open up new opportunities for Canopy Growth. Large multi-state operators, however, would also benefit from any reform in the U.S. Constellation Brands has been distancing itself from Canopy Growth, and that could have dire consequences for the cannabis producer.

Will Canopy Growth Still Be a Top Cannabis Stock in 5 Years?

Cannabis stocks have gained in the past couple of months following the federal government's reclassification of the drug. Experts also anticipate that the lobby to lift the ban on the U.S. financial institutions financing cannabis stocks and the reclassification may see the industry market value double to $57 billion by 2028.

News for Canopy Growth Stock (CGC)